Our practice in new drugs and pharmaceuticals and new medical techniques, as well as biotechnology and nanotechnology, has dramatically expanded in recent years. At the same time, cross-border commercial transactions, large-scale M&A and other corporate realignments by companies engaged in these industries have steadily risen. Driven by these developments, we have strengthened our Life Science & Chemical ("LSC") Practice by drawing upon and integrating our expertise and experience in the fields of Regulatory/Compliance, Intellectual Property, Product Liability/Dispute Resolution and Corporate/M&A, to address and solve legal issues related to life sciences, healthcare and specialty chemicals in a more focused and specialized way.

□Corporate/M&A
Mergers & Acquisitions
Joint Ventures
Corporate restructurings (e.g., spin offs, management buyouts)

□Regulatory/Compliance
Licenses and approvals under the Pharmaceutical Affairs Act
Advice on fair competition regulations
Advice on environmental regulations
Advice on chemical substances and regulations

□Intellectual Property
Patent Litigation
Patent Licenses
Patent Applications and Prosecutions

□Product Liability/Dispute Resolution
High technology product liability
Complex and large scale disputes

For further details regarding our LSC events or for any other inquiries, please contact your regular Anderson Mori & Tomotsune attorney or:

Yoshikazu Iwase
yoshikazu.iwase@amt-law.com
+81-3-6888-1069

Shiho Koizumi
shiho.koizumi@amt-law.com
+81-3-6888-1093

(Click here to print)